Zynerba (ZYNE) stock forecast for 2024

The forecast has been updated: January 20, 2022 7:59


Zynerba stock price online today

Analyst Target Price

6.58

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Zynerba stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Zynerba stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $6.58 target price for Zynerba stock stock.

Today 200 Day Moving Average is the resistance level (4.318 $).

50 Day Moving Average is the resistance level (3.552 $).




ZYNE Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 3.42 3.00 3.70 18.82 %
Feb 3.41 2.96 3.62 18.32 %
Mar 3.55 3.04 3.95 22.96 %
Apr 3.47 3.06 3.67 16.51 %
May 3.27 3.00 3.42 12.40 %
Jun 2.92 2.54 3.32 23.59 %
Jul 2.56 2.45 2.74 10.76 %
Aug 2.43 2.20 2.58 14.56 %
Sep 2.25 2.01 2.50 19.72 %
Oct 2.63 2.48 2.89 14.23 %
Nov 2.49 2.38 2.76 13.83 %
Dec 2.68 2.47 3.00 17.56 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Zynerba stock.


Zynerba overview

Zynerba Address

80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US

Market Capitalization

118 294 000 $

EBITDA

-36 895 716

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-1.043

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

-

Forward PE

-

EV To Revenue

397.61

EV To EBITDA

-

52 Week High

9

52 Week Low

2.675

50 Day Moving Average

3.552

200 Day Moving Average

4.318

Shares Outstanding

41217500

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Zynerba stock forecast for this year


Zynerba stock forecast for Jan 2024.
Estimated Average Forecasted Zynerba Price: 3.42. Positive monthly dynamics of the instrument is expected with 18.816% volatility is expected.

Pessimistic forecast: 3.00

Optimistic: 3.70


Zynerba stock forecast for Feb 2024.
Estimated Average Forecasted Zynerba Price: 3.41. Negative monthly dynamics of the instrument is expected with 18.319% volatility is expected.

Pessimistic forecast: 2.96

Optimistic: 3.62


Zynerba stock forecast for Mar 2024.
Estimated Average Forecasted Zynerba Price: 3.55. Positive monthly dynamics of the instrument is expected with 22.957% volatility is expected.

Pessimistic forecast: 3.04

Optimistic: 3.95


Zynerba stock forecast for Apr 2024.
Estimated Average Forecasted Zynerba Price: 3.47. Negative monthly dynamics of the instrument is expected with 16.509% volatility is expected.

Pessimistic forecast: 3.06

Optimistic: 3.67


Zynerba stock forecast for May 2024.
Estimated Average Forecasted Zynerba Price: 3.27. Negative monthly dynamics of the instrument is expected with 12.402% volatility is expected.

Pessimistic forecast: 3.00

Optimistic: 3.42


Zynerba stock forecast for Jun 2024.
Estimated Average Forecasted Zynerba Price: 2.92. Negative monthly dynamics of the instrument is expected with 23.593% volatility is expected.

Pessimistic forecast: 2.54

Optimistic: 3.32


Zynerba stock forecast for Jul 2024.
Estimated Average Forecasted Zynerba Price: 2.56. Negative monthly dynamics of the instrument is expected with 10.765% volatility is expected.

Pessimistic forecast: 2.45

Optimistic: 2.74


Zynerba stock forecast for Aug 2024.
Estimated Average Forecasted Zynerba Price: 2.43. Negative monthly dynamics of the instrument is expected with 14.563% volatility is expected.

Pessimistic forecast: 2.20

Optimistic: 2.58


Zynerba stock forecast for Sep 2024.
Estimated Average Forecasted Zynerba Price: 2.25. Negative monthly dynamics of the instrument is expected with 19.723% volatility is expected.

Pessimistic forecast: 2.01

Optimistic: 2.50


Zynerba stock forecast for Oct 2024.
Estimated Average Forecasted Zynerba Price: 2.63. Positive monthly dynamics of the instrument is expected with 14.226% volatility is expected.

Pessimistic forecast: 2.48

Optimistic: 2.89


Zynerba stock forecast for Nov 2024.
Estimated Average Forecasted Zynerba Price: 2.49. Negative monthly dynamics of the instrument is expected with 13.831% volatility is expected.

Pessimistic forecast: 2.38

Optimistic: 2.76


Zynerba stock forecast for Dec 2024.
Estimated Average Forecasted Zynerba Price: 2.68. Positive monthly dynamics of the instrument is expected with 17.565% volatility is expected.

Pessimistic forecast: 2.47

Optimistic: 3.00



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 126.05 (19.01.2022) -0.41 %
AbbVie Inc.
ABBV 135.21 (19.01.2022) -1.15 %
Aeterna Zentaris Inc.
AEZS 0.34 (18.01.2022) -5.48 %
Allakos Inc.
ALLK 7.43 (19.01.2022) 2.91 %
Allogene Therapeutics, Inc.
ALLO 11.68 (19.01.2022) -0.81 %
Amgen Inc.
AMGN 231.3 (19.01.2022) -1.08 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.22 (19.01.2022) 2.08 %
Aurora Cannabis Inc.
ACB 4.86 (19.01.2022) -4.89 %
Becton Dickinson and Company
BDX 263.87 (19.01.2022) 1.32 %
Biogen Inc.
BIIB 230.81 (19.01.2022) 0.00 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 118 (18.01.2022) -3.41 %
BioNTech SE
BNTX 161.66 (19.01.2022) -4.47 %
bluebird bio, Inc.
BLUE 7.55 (19.01.2022) -4.55 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 64.72 (19.01.2022) -0.26 %
Canopy Growth Corp.
CGC 7.64 (19.01.2022) -1.80 %
Castle Biosciences, Inc.
CSTL 33.17 (19.01.2022) -1.46 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 245.05 (19.01.2022) -0.82 %
Emergent BioSolutions Inc.
EBS 52.22 (14.01.2022) 5.54 %
Exelixis, Inc.
EXEL 17.08 (19.01.2022) -1.73 %
G1 Therapeutics, Inc.
GTHX 9.07 (19.01.2022) -0.44 %
Gilead Sciences, Inc.
GILD 69.07 (19.01.2022) -1.93 %
GlaxoSmithKline plc
GSK 45.69 (19.01.2022) -2.41 %
GoodRx Holdings, Inc.
GDRX 25.56 (19.01.2022) -1.31 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.01 (18.01.2022) 0.17 %
Inovio Pharmaceuticals, Inc.
INO 4.19 (19.01.2022) -1.99 %
Johnson & Johnson
JNJ 166.58 (19.01.2022) -0.31 %
Medtronic plc.
MDT 107.76 (19.01.2022) 0.25 %
Merck & Co., Inc.
MRK 81.29 (19.01.2022) -0.31 %
Moderna, Inc.
MRNA 174.07 (19.01.2022) -6.72 %
Novartis AG
NVS 88.85 (19.01.2022) -0.77 %
Novavax, Inc.
NVAX 92.33 (19.01.2022) -6.21 %
ObsEva SA
OBSV 1.76 (18.01.2022) -8.33 %
OrganiGram Holdings Inc.
OGI 1.54 (19.01.2022) -0.65 %
Pfizer Inc.
PFE 53.54 (19.01.2022) -1.05 %
Regeneron Pharmaceuticals, Inc.
REGN 618.11 (19.01.2022) 1.13 %
Sanofi
SNY 52.08 (19.01.2022) -0.17 %
Schrodinger, Inc.
SDGR 27.85 (19.01.2022) -3.27 %
Senseonics Holdings, Inc.
SENS 2.67 (19.01.2022) -3.61 %
Sorrento Therapeutics, Inc.
SRNE 4.23 (18.01.2022) -7.24 %
Stryker Corp.
SYK 260.48 (18.01.2022) -2.34 %
Sundial Growers Inc.
SNDL 0.5465 (18.01.2022) -3.10 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.84 (19.01.2022) -0.56 %
Thermo Fisher Scientific Inc.
TMO 590.1 (18.01.2022) -0.79 %
Tilray, Inc.
TLRY 6.29 (18.01.2022) -8.31 %
UnitedHealth Group, Inc.
UNH 468.69 (14.01.2022) 0.27 %
Veeva Systems Inc.
VEEV 218.27 (18.01.2022) -2.49 %
Zomedica Corp.
ZOM 0.336 (19.01.2022) -4.00 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.45 (18.01.2022) -6.84 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.